MedTrace Logo

Artificial Intelligence in Computed Tomography for Quantifying Lung Changes of Bronchiectasis Patients

NCT05751538 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 730

Last updated 2023-03-02

No results posted yet for this study

Summary

Bronchiectasis is a chronic respiratory disease characterized by permanent bronchiectasis.The incidence and prevalence of bronchiectasis have assumed continuously grows in global. Chest computed tomography (CT) remains the imaging standard for demonstrating cystic fibrosis (CF) airway structural disease in vivo. However, visual scoring systems as an outcome measure are time consuming, require training and lack high reproducibility. Our objective was to validate a fully automated artificial intelligence (AI)-driven scoring system of CF lung disease severity.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-06-30
Completion
2023-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05751538 on ClinicalTrials.gov